A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge

Clinical trial NCT01539473 · COMPLETED

Trial details

NCT number: NCT01539473
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2012-02-01
Primary completion: 2012-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.